Medicine Is Making
Real Progress

AI is dramatically accelerating drug discovery from years to months, bringing treatments to patients faster.

Canine plasma therapy receives FDA clearance, opening new treatment possibilities.

New AI model helps predict clinical trial success, potentially accelerating drug development timelines.

Mayo Clinic and JETRO are supporting fifteen innovative Japanese healthcare startups in breakthrough medical technology.

Scientists discover the link between post-surgery delirium and dementia, opening treatment pathways.

A new weight loss drug has been approved for use in the UK, offering patients a new treatment option.

New breakthrough offers promise for changing how metastatic prostate cancer is treated, potentially improving patient outcomes.

Clinical trials are bringing research breakthroughs closer to patients in local communities.

A new drug shows promise in preventing COVID-19 infection after exposure.

Eli Lilly provides early access to an innovative weight loss drug for patients, offering hope before formal FDA approval.

Fridge-free vaccines successfully tested, potentially revolutionizing global vaccine distribution and accessibility.

Scientists uncover promising new treatment opportunities for brain cancer, opening multiple pathways for therapeutic development.

AI is accelerating drug discovery, potentially bringing life-saving medications to patients faster than ever before.

Local community member shares positive health outlook following recent medical concerns.

A breakthrough drug gives a Utah grandfather with pancreatic cancer renewed hope for recovery and extended quality time with his family.

FDA approval of a new narcolepsy drug opens doors for an entirely new class of effective treatments.

Community conversations are successfully preventing HIV infections in Kenya, offering hope through grassroots education.

AI successfully identifies new health insights in routine sleep studies, potentially improving diagnosis and treatment.

Takeda's approval marks the beginning of a new wave of sleep disorder medications that will help millions of patients.

A new treatment shows promising potential to help the immune system fight KRAS-driven tumors, offering hope for difficult-to-treat cancers.

FDA approval of a new narcolepsy drug opens doors for an entirely new class of treatments.

A new highly effective 'Triple G' weight loss drug offers patients a promising treatment option.

Researchers supported by the V Foundation are sharing exciting cancer research breakthroughs that offer new therapeutic possibilities.

A novel KRAS G12C inhibitor receives Breakthrough Therapy designation for previously treated advanced pancreatic cancer patients.

CUSAT's patent for a green mussel-based cancer research approach represents an innovative breakthrough in natural compounds for cancer treatment.

New medications and guidelines are transforming cholesterol management, offering patients better tools for cardiovascular disease prevention.

A major medical institution receives funding to advance health equity and improve care for pregnant patients.

Teenagers gain hands-on experience in cancer research, inspiring the next generation of researchers to fight the disease.

New human-centric approaches are transforming drug discovery to be more effective and efficient.

Yale Medicine offers new hope for pancreatic cancer patients with emerging treatment advances.

Researchers funded by the V Foundation announce significant cancer research breakthroughs.

FDA approval of Pluvicto offers patients a new standard-of-care option for metastatic prostate cancer.

The FDA approves two innovative nonmedication treatment options that offer new hope for PTSD patients.

Karyopharm advances selinexor combination therapy toward FDA approval for myelofibrosis under expedited review.

Robotic phlebotomy system achieves 94.5% success rate, potentially improving patient comfort during blood draws.

HAART therapy transformed HIV from a death sentence into a manageable chronic condition, giving millions a second chance at life.

Groundbreaking Stanford-led trial demonstrates safe eating is now possible for children with food allergies.

A pediatric patient achieves positive results in a clinical trial, offering hope for improved treatments.

An advanced wound sealant technology receives breakthrough designation to help patients heal better.

FDA approves a fast-acting non-opioid pain relief medication combining Tylenol and Naproxen, offering patients safer pain management alternatives.

A clinical trial demonstrates excellent safety results for kidney disease patients with anemia, offering hope for a new treatment option.

New non-invasive handheld sound-based therapy shows promise for treating cancer.

A cancer treatment discovery led to a groundbreaking HIV treatment that transformed medical understanding and patient care.

Outlook Therapeutics gains FDA approval for a new AMD drug, providing patients with additional treatment options.

FDA approval of centanafadine provides new ADHD treatment option for children, adolescents, and adults.

A pharmaceutical company secures significant funding following FDA approval of an innovative new treatment.

Otsuka's FDA approval of an ADHD drug opens an entirely new drug class, expanding treatment options for patients.

Researchers are making meaningful progress toward solutions for hearing loss, offering hope to millions affected by this condition.

FDA approval of eye disease drug expands treatment options for patients with vision-threatening conditions.

A newly FDA-approved ADHD medication offers patients a different approach to treatment.

New initiatives are addressing critical gaps in blood disorder treatment, research, and patient support.

Johns Hopkins AI breakthrough can detect pancreatic cancer earlier than traditional methods, potentially saving lives.

New hope emerges with a potential treatment for the deadly Ebola strain affecting the DRC.

Community health initiative brings engaging healthcare education to children through a fun, interactive clinic event.

China approves innovative drug ciprocopan succinate as a new treatment option for patients with paroxysmal nocturnal hemoglobinuria.

AI-powered tools are accelerating drug discovery by identifying better therapeutic targets more efficiently.

The US is investing $5 billion in AI research to accelerate drug discovery, potentially bringing life-saving treatments to patients faster.

Groundbreaking gene therapy discovery offers hope for hereditary deafness treatment.

China approves a new narcolepsy drug, expanding treatment options for patients with this sleep disorder.